Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials

被引：0
|
作者：
Reich, Kristian [1 ]
Langley, Richard G. [2 ]
Silvestre, Juan Francisco [3 ]
Staumont-Salle, Delphine [4 ]
Costanzo, Antonio [5 ]
Pink, Andrew [6 ]
Paller, Amy [7 ]
Katoh, Norito [8 ]
Wollenberg, Andreas [9 ]
Warren, Richard B. [10 ]
Oland, Christian Bjerregard [11 ]
Tindberg, Ann-Marie [11 ]
Gjerum, Le [11 ]
Simpson, Eric [12 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Gen Univ Dr Balmis, ISABIAL, Alicante, Brazil
[4] Univ Lille, Lille, France
[5] Humanitas Univ, Milan, Italy
[6] Guys & St Thomas Hosp, St Johns Inst Dermatol, London, England
[7] Northwestern Univ, Chicago, IL USA
[8] Kyoto Prefectural Univ Med, Kyoto, Japan
[9] Ludwig Maximilian Univ Munich, Munich, Germany
[10] Univ Manchester, Manchester, England
[11] LEO Pharma AS, Ballerup, Denmark
[12] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
atopic dermatitis; tralokinumab; IL-13; safety;
D O I：
10.1093/bjd/ljae266.028
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
649
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice
    Schloesser, Anne R.
    Shareef, Madena
    Olydam, Jill
    Nijsten, Tamar E. C.
    Hijnen, Dirk Jan
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (05) : 510 - 517
  • [32] Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab-induced psoriasis
    Quattrini, L.
    Caldarola, G.
    Falco, G. M.
    Pinto, L. M.
    Peris, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : E1432 - E1434
  • [33] Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta-analysis of randomized clinical trials
    Han, Yue
    Chen, Yuxin
    Liu, Xiaochun
    Zhang, Jingxi
    Su, Huichun
    Wen, He
    Li, Wei
    Yao, Xu
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (03) : 888 - +
  • [34] Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials
    Xiao, X.
    Lin, L.
    Zhu, C.
    Yang, X.
    Ni, Y.
    Zhipeng, L.
    Chong, J.
    Han, Y.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (02) : 190 - 192
  • [35] Effectiveness and safety of tralokinumab treatment for moderate-to-severe atopic dermatitis in real-world clinical practice in Japan
    Hagino, Teppei
    Onda, Marina
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    EUROPEAN JOURNAL OF DERMATOLOGY, 2024, 34 (05) : 525 - 532
  • [36] Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis
    Chovatiya, Raj
    Wollenberg, Andreas
    Ribero, Simone
    Saeki, Hidehisa
    Oland, Christian B.
    Steffensen, Louise A.
    Tindberg, Ann-Marie
    Thyssen, Jacob P.
    Blauvelt, Andrew
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II49 - II50
  • [37] Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis
    Chovatiya, Raj
    Wollenberg, Andreas
    Ribero, Simone
    Saeki, Hidehisa
    Oland, Christian B.
    Steffensen, Louise A.
    Tindberg, Ann-Marie
    Thyssen, Jacob P.
    Blauvelt, Andrew
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [38] Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28-Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
    Dekkers, Coco
    Zuithoff, Nicolaas
    Bakker, Daphne
    Knol, Edward
    Wevers, Anne
    Touwslager, Wouter
    Christoffers, Wianda
    Prosje, Petra
    van Lynden-van Nes, Anneke
    van Lumig, Paula
    Kamsteeg, Marijke
    Oosting, Albert Jan
    Schuttelaar, Marie L. A.
    Haeck, Inge
    de Graaf, Marlies
    van Wijk, Femke
    de Bruin-Weller, Marjolein
    ALLERGY, 2024,
  • [39] Efficacy and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis: meta-analysis of randomized clinical trials
    Labedz, Natalia
    Pawliczak, Rafal
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2019, 36 (06): : 752 - +
  • [40] Safety Profile of Ixekizumab for the Treatment of Psoriatic Arthritis and Axial Spondyloarthritis Up to 3 Years: an Updated Integrated Safety Analysis
    Schwartzman, Sergio
    Deodhar, Atul
    Combe, Bernard
    Accioly, Ana
    Kronbergs, Andris
    Janos, Boris
    Zhu, Danting
    Sandoval, David
    Rahman, Proton
    Poddubnyy, Denis
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 828 - 828
12345